Information Library
Market Intelligence
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Market Intelligence and Analytics for Oncology
November 18, 2009
Discover Quintiles’ Market Intelligence and Analytics consulting solution for oncology. -
Quintiles Consultant wins National Recognition
November 18, 2009
Jim Kirk receives PMRG President’s Award at the Fall conference. -
PMRG 2009 Presentation "Wisdom of Crowds"
November 17, 2009
Consulting’s Market Intelligence presentation on Wisdom of Crowds at PMRG 2009 Annual Conference -
PMRG 2009 Insight Brief
November 17, 2009
Insights from PMRG 2009 Fall Conference -
Market Intelligence and Analytics
November 13, 2009
Learn more about Quintiles’ Market Intelligence and Analytics consulting solution. -
Comparative Effectiveness Research as a Drug Development Tool
September 1, 2009
A Q&A with John Doyle, Vice President and Practice Leader of Quintiles Consulting, sheds light on the complex issue of comparative effectiveness research, and its strategic importance in successful and efficient biopharmaceutical development. -
Diagnosing an Underperforming Drug
August 19, 2009
Learn how Eidetics uncovered barriers to market success for a customer’s new product launch and delivered insights to optimize marketing and sales strategies. -
For Investigors: Market Situation
July 17, 2009
Learn about the clinical trial market situation. -
Poised for success
June 16, 2009
Learn how a holistic life cycle approach can improve your commercial organization's productivity and flexibility -
Charting a New Course by Catalyzing Transformation
June 9, 2009
Adrian McKemey, Quintiles Consulting Product Development and Commercialization Practice Leader, and Michael Arlotto, Senior Vice President Corporate Development Quintiles, discuss how organizations are transforming their clinical organizations to more effectively deliver safer drugs.